New AAAAI data spotlight oral remibrutinib for CSU, next-generation peanut allergy therapies, infant microbiome prevention, and GLP‑1 receptor agonists linked to fewer asthma flares.
Monica Dougherty, PharmD, BCACP
Advertisement
Articles by Monica Dougherty, PharmD, BCACP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
A Paradigm Shift in Lipid Management: Highlights from the NLA 2026 Scientific Sessions Opening Session
2
Staging the Heart: NLA and EAS Reveal a New Era of Precision Lipidology and Imaging
3
ATTR-CM Red Flags, Treatment Evidence, and the Pharmacist's Role in Care
4
FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant Treatment of High-Risk Clear Cell RCC
5